EarliPoint Health receives expanded FDA clearance for autism assessment in children up to age 8.

Read Release →

Articles

Exploring the science, practice, and people shaping the future of early developmental evaluation.

The Importance of Eye Contact in Your Baby’s Development—and When to Worry

As a parent, watching your baby’s development is an exciting journey filled with milestones like their first smile, laugh, and steps. One […]

…

Don’t Wait to Act: Spot the Signs of Autism Before Your Child Turns 3

Why Early Detection Matters Every child develops at their own pace, but when certain social, communication, or behavioral milestones are missing, it […]

…

Beyond Observation: Why Objective Data Is Essential for Understanding Learning

Every year, thousands of children miss critical windows for early autism intervention—simply because diagnostic tools rely too much on subjective observation.20,31-37 Once that […]

…

Social Media Strategies for ABA Clinics: Building Trust, Awareness, and Engagement

Key Takeaways For ABA clinics, social media isn’t just a place to post occasional updates—it’s a powerful tool for connecting with families, […]

…

Marketing for ABA Practices: Choosing the Right Marketing Channels to Toolkit to growing practice

Key Takeaways Growing an ABA therapy practice takes more than delivering excellent care—it’s about making sure the families who need you can […]

…

Local SEO for ABA Clinics: A Practical Guide to Attract More Families in Your Area

Key Takeaways For ABA clinics, the families you want to serve are often searching close to home. Parents want providers within a […]

…
Request A Demo

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder